INVO Fertility (IVF) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
INVO Fertility (IVF) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.96% |
| 10 | INVO Fertility | 2.24 Mn | 2.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.36% |
| Dec 31, 2025 | -4.02% |
| Sep 30, 2025 | -3.87% |
| Jun 30, 2025 | -3.22% |
| Mar 31, 2025 | -2.84% |
| Dec 31, 2024 | -2.37% |
| Sep 30, 2024 | -21.37% |
| Jun 30, 2024 | 51.41% |
| Mar 31, 2024 | 47.03% |
| Dec 31, 2023 | 84.21% |
| Sep 30, 2023 | 93.87% |
| Jun 30, 2023 | 82.48% |
| Mar 31, 2023 | 55.51% |
| Dec 31, 2022 | 67.43% |
| Sep 30, 2022 | 68.39% |
| Jun 30, 2022 | 68.94% |
| Mar 31, 2022 | 81.93% |
| Dec 31, 2021 | 144.17% |
| Sep 30, 2021 | 281.04% |
| Jun 30, 2021 | 100.82% |